RCAN1-mediated calcineurin inhibition as a target for cancer therapy

RCAN1-mediated calcineurin inhibition as a target for cancer therapy

Abstract Cancer is the leading cause of mortality worldwide. Regulator of calcineurin 1 (RCAN1), as a patent endogenous inhibitor of calcineurin, plays crucial roles in the pathogenesis of cancers. Except for hypopharyngeal and laryngopharynx cancer, high expression of RCAN1 inhibits tumor progressi...

Full description

Bibliographic Details
Main Authors: Mengyi Lao, Xiaozhen Zhang, Hanshen Yang, Xueli Bai, Tingbo Liang
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Molecular Medicine
Subjects:
RCAN1
Calcineurin
Cancer therapy
Online Access:https://doi.org/10.1186/s10020-022-00492-7

Similar Items

Similar Items